Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Clinical Pharmacology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Clinical Pharmacology
    Denosumab Offers Breakthrough in Treatment of Inoperable Giant-Cell Tumour - (DGNews)
    Duloxetine Directly Improves Pain in Patients With Fibromyalgia and Depression: Presented at AAPM - (DGDispatch)
    Intravenous Acetaminophen Reduces Pain, Opioid Consumption After Hip or Knee Surgery: Presented at AAPM - (DGDispatch)
    Methylnaltrexone for Opioid-Induced Constipation Does Not Adversely Affect Pain, Withdrawal Symptoms: Presented at AAPM - (DGDispatch)
    Sodium Oxybate Improves Pain, Function in Patients With Fibromyalgia: Presented at AAPM - (DGDispatch)

    News archive

     Recent webcasts/CME - Clinical Pharmacology
    • Translating Guidelines Into Practice: An Expert Roundtable Discussion of Optimal Antiplatelet Therapy in Acute Coronary Syndrome
    • Current State of the Art in Antiplatelet Therapy in Clinical Practice: Results From the Field
    • The Future of Antiplatelet Therapy in Patients With ACS: Can We See it From Here?
    • Tools for Supporting Optimal Fibromyalgia Diagnosis and Treatment: An Update for Primary Care and Managed Care
      Deep Vein Thrombosis in Focus: Expert Perspectives on Reducing the Burden of Venous Thromboembolism

      Webcasts/CME archive

       Recent cases - Clinical Pharmacology
        The Influence Of Hepatitis C Infection And Interferon-alpha Therapy On Thyrotropin Blocking And Stimulating Autoantibodies In Graves' Ophthalmopathy: A Case Report
        Sigma-1 Receptor Agonist Fluvoxamine For Delirium In Patients With Alzheimer's Disease
        Olanzapine And Pulmonary Embolism, A Rare Association: A Case Report
        Anti-Inflammatory Effects Of Antidepressant And Atypical Antipsychotic Medication For The Treatment Of Major Depression And Comorbid Arthritis: A Case Report
        Etanercept And Venous Thromboembolism: A Case Series

        Cases archive
          




        my personal edition > clinical pharmacology > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Modafinil And D-Amphetamine Action On Electroencephalogram

        A DGReview of :"Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG"
        Psychopharmacology

        03/21/2003
        By Robert Short


        The alertness-promoting effects of modafinil and d-amphetamine involve distinct electroencephalogram activities.

        This is one conclusion resulting from a double-blind, placebo-controlled parallel design study led by Dr Florian Chapotot of the Département des Facteurs Humain, Centre de Recherches du Service de Santé des Armées, La Tronche Cedex, France.

        Thirty three healthy subjects were investigated during 60 hours of sustained wakefulness. The objective of the study was to determine whether modafinil (300 mg), in comparison to the d-amphetamine (20mg) reference psychostimulant and to placebo, interferes with the vigilance regulatory processes reflected in the EEG during waking.

        It was found that one hour after ingestion, both the psychostimulants increased alertness during 10 to 12 hours, independently of the time of administration. At the level of the waking EEG, d-amphetamine attenuated the natural circadian rhythm of the different frequency bands and suppressed the sleep deprivation-related increase in low frequency powers.

        In contrast, modafinil had slight effect on circadian rhythms. Its selective action was characterized by maintenance of the alpha1 EEG power, which under placebo exhibited a homeostatic decrease paralleling that of alertness with a circadian trough at night.

        The researchers said, "These findings demonstrate that the alertness-promoting effects of modafinil and d-amphetamine involve distinct EEG activities and do not reside on the same vigilance regulatory processes. While d-amphetamine inhibits the expression of a sleep-related process, probably through a direct cortical activation masking EEG circadian rhythms, modafinil, through a synchronic effect , preferentially disrupts the homeostatic down-regulation of a waking drive."
        Psychopharmacology 2003;166:127-138. "Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send